Alexion Pharmaceuticals, Inc.

Alexion Pharmaceuticals, Inc.

Alexion Pharmaceuticals, Inc.


Alexion Pharmaceuticals Inc. is an American pharmaceutical company that specializes in orphan drugs to treat rare diseases. The company is best known for its development of Soliris, a drug used to treat the rare disorders atypical hemolytic uremic syndrome and paroxysmal nocturnal hemoglobinuria. It is a subsidiary of AstraZeneca and is headquartered in Boston, Massachusetts. 

View Scores for Each Issue

Become a Subscriber or join the Investor's Council

Want to see how this organization scores for each individual issue? Click here.

Overall score: 1.00

  1. Life 3.00
  2. Basic Freedoms 3.00
  3. 2nd Amendment 3.00
  4. Civil-Safe Society 3.00
  5. Education 3.00
  6. Environment 3.00

View Our Research

Become an Investor's Council Member

If you would like to see more details about how we arrive at these scores, including information about where this company donates money and what causes it supports, click here.

Take Action

Reach out to Alexion Pharmaceuticals, Inc. on social media:

Send Alexion Pharmaceuticals, Inc. a message: